Rheumatoid arthritis (RA) is a long-term autoimmune condition that causes joint pain, swelling, and progressive loss of function.
A recent real-world study published in a medical journal explored whether an artificial intelligence (AI)–assisted digital care platform could improve outcomes for people with RA after discharge.
One group received standard post-discharge care, while the other used a nurse-led digital management platform supported by AI.
Medication adherence was also higher in the digital care group, with more patients taking their medications as prescribed.
A large majority of patients using the platform reported being very satisfied with their care experience compared with the standard care group.
Rheumatoid arthritis (RA) is a long-term autoimmune condition that causes joint pain, swelling, and progressive loss of function. Managing it well after patients leave the hospital is often difficult, since symptoms can fluctuate and regular follow-up is not always easy. A recent real-world study published in a medical journal explored whether an artificial intelligence (AI)–assisted digital care platform could improve outcomes for people with RA after discharge.
The study, published in JMIR Medical Informatics, and conducted by Ziyun Zhang, PhD., and colleagues at Tongji Hospital, followed 341 patients with rheumatoid arthritis over a six-month period in a real clinical setting.
Participants were divided into two groups. One group received standard post-discharge care, while the other used a nurse-led digital management platform supported by AI. The platform allowed patients to report symptoms, fatigue, medication use, lab results and emotional wellbeing through a smartphone app. This information was stored securely and analyzed in real time. If the system detected concerning changes, healthcare staff were alerted so they could respond quickly. Nurses and health coaches also provided ongoing education and personalized support.
The study focused on how patients’ disease activity, physical function, medication adherence and satisfaction changed over time. Researchers used standard clinical tools to measure disease severity and disability.
After six months, both groups showed some improvement, but the differences between them were notable. Patients using the AI-supported platform experienced a greater reduction in disease activity scores, meaning their arthritis was better controlled. They also showed significant improvements in physical function compared with those receiving routine care alone.
Medication adherence was also higher in the digital care group, with more patients taking their medications as prescribed. In addition, satisfaction levels were significantly higher. A large majority of patients using the platform reported being very satisfied with their care experience compared with the standard care group.
The authors conclude that the combination of AI monitoring, nurse-led support, and continuous digital engagement helped improve both clinical outcomes and patient experience. The system made it easier to detect problems early, encourage medication use and provide more personalized care between clinic visits.
Overall, the study suggests that digital health platforms could play an important role in improving long-term management of rheumatoid arthritis, especially by keeping patients more closely connected to their care teams after leaving the hospital.
